52,155 Axon Enterprise, Inc $AXON Shares Acquired by Quadcap Wealth Management LLC

Key Points

• Quadcap Wealth Management sharply increased its Axon stake, buying 52,155 shares in the third quarter—a 3,108.2% increase—to reach 53,833 shares valued at about $22.7 million.
• Axon’s third-quarter revenue rose 27.8% year over year to $908.6 million, but missed analyst estimates; adjusted earnings of $1.72 per share also fell short of the $1.89 consensus.
• Shares were reported down 9.8%, as Axon’s revenue outlook for both the fourth quarter and full year came in below analyst expectations.

Quadcap Wealth Management LLC increased its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 3,108.2% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 53,833 shares of the biotechnology company's stock after buying an additional 52,155 shares during the period. Axon Enterprise accounts for about 2.1% of Quadcap Wealth Management LLC's holdings, making the stock its 8th largest holding. Quadcap Wealth Management LLC owned 0.07% of Axon Enterprise worth $22,746,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. State Street Corp grew its stake in shares of Axon Enterprise by 5,700.2% in the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company's stock worth $119,724,905,000 after acquiring an additional 209,879,882 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Axon Enterprise by 18,050.2% during the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company's stock valued at $7,400,094,000 after acquiring an additional 13,127,348 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its position in shares of Axon Enterprise by 391,214.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company's stock worth $2,952,943,000 after purchasing an additional 6,987,098 shares during the last quarter. Assenagon Asset Management S.A. raised its position in shares of Axon Enterprise by 5,022.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company's stock worth $1,802,719,000 after purchasing an additional 4,183,302 shares during the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in shares of Axon Enterprise by 8,432.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company's stock worth $1,983,414,000 after purchasing an additional 3,496,493 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the business's stock in a transaction on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares in the company, valued at approximately $27,032,038.80. The trade was a 1.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. The trade was a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 37,397 shares of company stock worth $21,234,034 over the last quarter. 4.20% of the stock is currently owned by insiders.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

Axon Enterprise Trading Down 9.8%

Shares of NASDAQ:AXON opened at $382.56 on Friday. The company has a market cap of $31.08 billion, a P/E ratio of 158.74, a PEG ratio of 8.06 and a beta of 1.48. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $665.07. The stock's fifty day moving average price is $447.49 and its 200-day moving average price is $476.73.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business had revenue of $908.55 million during the quarter, compared to the consensus estimate of $934.33 million. During the same quarter in the previous year, the business posted $1.17 earnings per share. Axon Enterprise's quarterly revenue was up 27.8% compared to the same quarter last year. Sell-side analysts expect that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Analyst Ratings Changes

AXON has been the subject of a number of analyst reports. Weiss Ratings restated a "hold (c-)" rating on shares of Axon Enterprise in a research note on Tuesday. Argus upped their target price on shares of Axon Enterprise from $460.00 to $600.00 and gave the stock a "buy" rating in a research note on Thursday, September 3rd. Piper Sandler dropped their target price on shares of Axon Enterprise from $732.00 to $561.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 20th. Needham & Company LLC reiterated a "buy" rating on shares of Axon Enterprise in a report on Tuesday, October 27th. Finally, UBS Group raised their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a research report on Thursday, August 6th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus price target of $688.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.